http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10188344-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ad9deced45656b1526b0ccef0ca79e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75f2c746d26308e6d48c241edd8d2be9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-032
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16Z99-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16Z99-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-00
filingDate 2013-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5a01fd6f03c6fdd1d8cbb8a3f5eac8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_520fa81c042c3d236c4bde84e78e3d43
publicationDate 2019-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10188344-B2
titleOfInvention Optimum administration form providing system for magnetic drug
abstract A system capable of designing an optimum administration form of a magnetic drug is provided. The system determines first information about an side-effect-related organ on which a magnetic drug produces a side effect, based on equipment analysis information after administering the magnetic drug; further determines second information about a drug-efficacy-related organ in which drug efficacy of the magnetic drug should be demonstrated; evaluates the administration form of the magnetic drug based on the first information and the second information; corrects the administration form of the magnetic drug based on an evaluation result; and outputs information of the corrected administration form.
priorityDate 2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8954131-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7505807-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007297290-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004242676-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009311163-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26518

Total number of triples: 39.